Home/Filings/4/0001209191-12-053282
4//SEC Filing

Arcudi III Louis J 4

Accession 0001209191-12-053282

CIK 0000861838other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 4:46 PM ET

Size

5.8 KB

Accession

0001209191-12-053282

Insider Transaction Report

Form 4
Period: 2012-11-13
Arcudi III Louis J
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-11-13+33,500146,000 total
    Exercise: $1.16Exp: 2021-11-28Common Stock (33,500 underlying)
Footnotes (1)
  • [F1]On December 5, 2011, the reporting person was granted an option to purchase up to an aggregate of 200,000 shares of common stock. Half of the shares subject to such option are subject to satisfaction of performance vesting criteria. On November 13, 2012, certain performance vesting criteria were met with respect to 33,500 of such shares, of which 8,375 shares vested on November 13, 2012 and the remaining 25,125 of which will vest in three equal annual installments beginning on November 13, 2013.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeother

Related Parties

1
  • filerCIK 0001419350

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:46 PM ET
Size
5.8 KB